Cite

HARVARD Citation

    Lode, H. et al. (n.d.). Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record